Similar to pulmonary fibrosis, inhibiting IL11 signaling suppresses the phosphorylation of Erk, thereby reducing liver fibrosis in NASH mice [44]. Here, MAPK1 is linked to metabolic dysfunction-associated steatohepatitis.